Publications by authors named "Yuki M F Andersen"

Article Synopsis
  • - The study investigates the prevalence of risk factors associated with oral Janus kinase inhibitors (JAKis) in patients with chronic hand eczema (CHE), highlighting concerns due to their black-box warnings for infections, cancer, and cardiovascular issues.
  • - In a cohort of 941 CHE patients, 81.6% possessed at least one risk factor, with the majority being nonmodifiable; common risks included heavy smoking, obesity, hypercholesterolemia, and hypertension.
  • - The findings suggest that healthcare providers should carefully evaluate these risk factors when considering oral JAKi treatments for CHE, as most patients have conditions that could complicate their use.
View Article and Find Full Text PDF

Background: Alopecia areata (AA) and atopic dermatitis (AD) are chronic skin diseases where the suboptimal medication adherence (MA) may result in poor clinical outcomes.

Objective: To assess the impact of AA on MA among adults compared to AD.

Methods: Patient reported MA of adults with AA were compared with AD.

View Article and Find Full Text PDF

Background: Children with atopic dermatitis (AD) may have disturbed sleep, affected self-esteem and decreased quality of life, likely interfering with performance in school.

Objectives: To examine the association between hospital-managed paediatric AD, school performance and cognitive function.

Methods: In this cross-sectional study we linked data from the Danish national registers and identified three populations between 2001 and 2019.

View Article and Find Full Text PDF

Purpose: Alopecia areata (AA) is a common disorder of patchy hair loss which carries a substantial psychological burden for patients. The current understanding of AA prevalence, disease course and burden is limited, and further research is needed to improve patient care. This prospective cohort of AA patients within the Danish Skin Cohort was established to provide data that can serve as a tool in future studies of for example, AA epidemiology and disease burden.

View Article and Find Full Text PDF

Background: Parents of children with atopic dermatitis (AD) report reduced quality of life and higher stress level, which could increase risk of psychiatric and pain disorders, and medication use.

Methods: By use of Danish national registries, we identified family members of all first-born Danish children born between 1 January 1995 and 31 December 2013 with a hospital diagnosis of AD, matched them 1:10 with family members of children without AD, and followed the cohorts over time.

Results: Mothers of children with hospital-managed AD had higher risk of filling a prescription for medications for depression, anxiety, pain and sleep problems, and of consulting a psychologist, but most associations disappeared after full adjustment.

View Article and Find Full Text PDF

Importance: Questionnaire studies are important for estimating the prevalence of psoriasis and atopic dermatitis; however, validity among the adult population remains an important concern.

Objective: To examine the test-retest accuracy of questionnaires for measuring psoriasis and atopic dermatitis prevalence in an adult population.

Design, Setting, And Participants: This nationwide population-based cohort study administered questionnaires on psoriasis and atopic dermatitis to the same 2333 and 2312 randomly selected adults (≥18 years) in Denmark, respectively, at 2 different time points from May 15, 2018, to November 20, 2020.

View Article and Find Full Text PDF

Importance: Systemic and inhaled corticosteroids negatively affect bone remodeling and cause osteoporosis and bone fracture when given continuously or in high doses. However, risk of osteoporosis and major osteoporotic fracture (MOF) after application of topical corticosteroids (TCSs) is largely unexplored.

Objective: To examine the association between cumulative exposure to potent and very potent TCSs and risk of osteoporosis and MOF.

View Article and Find Full Text PDF

Little is currently known about possible associations between disease specific characteristics of atopic dermatitis (AD) and use of medical treatments. We explored the use of AD treatments within the past 12 months in Danish adults according to distinct patient characteristics. Patients who had received a diagnosis of AD in a hospital in- or outpatient setting as adults were surveyed and data cross-linked to a national prescription registry.

View Article and Find Full Text PDF

Background: Psoriasis is a common inflammatory skin disease associated with several immune-mediated inflammatory diseases (IMIDs); however, little is known of the chronology of disease development.

Objective: To investigate the chronology of IMIDs relative to psoriasis.

Methods: We utilized routinely collected data from Danish nationwide administrative registries to examine the occurrence of IMIDs in patients with psoriasis (n = 10,923) and general population controls (n = 109,230).

View Article and Find Full Text PDF

Objective: Topical corticosteroids (CSs) are commonly used to treat inflammatory skin conditions including eczema and psoriasis. Although topical CS package inserts describe hyperglycemia and glycosuria as adverse drug reactions, it is unclear whether topical CS use in real life is also associated with an increased risk of type 2 diabetes (T2D).

Research Design And Methods: Two matched case-control studies and one cohort study were conducted using routinely collected health care data from Denmark and the U.

View Article and Find Full Text PDF

Background: Wide-ranging psoriasis prevalence estimates have been reported, possibly due to methodological differences.

Objectives: To assess the prevalence of psoriasis in Denmark and to validate the use of questionnaire-based data to identify patients with psoriasis.

Methods: We used data from the Danish Skin Cohort, a prospective cohort comprising general population adults, as well as patients with dermatologist-verified psoriasis and atopic dermatitis, respectively.

View Article and Find Full Text PDF

Purpose Of Review: In this review article, we summarize the current evidence about atopic dermatitis (AD)-associated comorbidities, beyond the traditional atopic and allergic conditions.

Recent Findings: Patients with AD may have an increased risk of cardiovascular diseases, certain malignancies, autoimmune diseases, and neuropsychiatric diseases. The causes of these associations are likely multifactorial and may include genetic predispositions, systemic low-grade inflammation, environmental exposures, medication, and lifestyle and behavioral risk factors.

View Article and Find Full Text PDF

Adult atopic dermatitis (AD) is associated with overweight, obesity and cardiovascular diseases (CVD) in Americans, similarly to psoriasis, but no increased risk of CVD has been shown in European patients with AD. This study investigated the prevalence and risk of gallstones in adults with AD and in those with psoriasis as a proxy for obesity using nationwide data for all Danish citizens ≥ 30 years of age. Outcome was a diagnosis of gallstones.

View Article and Find Full Text PDF

Background: An increased susceptibility to autoimmune disease has been shown in patients with atopic dermatitis (AD), but data remain scarce and inconsistent.

Objective: We examined the co-occurrence of selected autoimmune diseases in adult patients with AD.

Methods: Nationwide health registers were used.

View Article and Find Full Text PDF

Background: Psoriasis and atopic dermatitis (AD) are chronic inflammatory skin disorders. Mortality is increased in psoriasis, yet no studies on mortality in AD are currently available.

Objective: We investigated 10-year mortality after hospitalization for AD compared with psoriasis and the general population.

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition with a multifactorial etiopathogenesis. Studies have suggested that several perinatal factors may influence the risk of AD in early childhood. We investigated possible neonatal risk factors such as jaundice, blue light phototherapy, birthweight, gestational age at birth, and season of birth on the risk of developing AD in the first 5 years of life.

View Article and Find Full Text PDF